The story appears on

Page A5

July 19, 2010

GET this page in PDF

Free for subscribers

View shopping cart

Related News

Home » Metro » Health and Science

Hope for transplant patients

MEDICAL experts in Shanghai are developing a novel therapy that will allow organ transplant patients to take less anti-rejection drugs, medical experts told an international forum in the city yesterday.

The therapy works by reorganizing regulatory T cells, which are responsible for most immune system reactions, thus a patient's immune system will be less likely to attack the transplanted organ.

Currently, patients require anti-rejection drugs to survive after receiving an organ transplant. The drugs are expensive, have strong side effects and need to be taken for a long time.

According to Dr Fan Hui-min from Shanghai East Hospital's department of cardiology, regulatory T cells have been receiving a great deal of attention in the international medical field. The cells are capable of inhibiting most types of immune responses by not only maintaining immunological self-tolerance but also by limiting responses to foreign objects to the body.


Copyright © 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.

沪公网安备 31010602000204号

Email this to your friend